LA HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
OSI Systems Inc. said its fiscal first-quarter profit rose 33 percent as it saw broad sales growth and improved margins for its security and medical scanners and optical component systems. The company also raised its guidance for the year.
Shares of Puma Biotechnology Inc. largely maintained their value on Monday in their second day of trading on the New York Stock Exchange, falling just 3 percent during a volatile day for the broader markets.
Shares of Puma Biotechnology Inc. jumped more than 35 percent on Friday after the company priced an offering of 7.5 million new shares in conjunction with a move from the Over-the-Counter Bulletin to the New York Stock Exchange.
MannKind Corp.’s share price fell by nearly a quarter on Thursday after the biotech confirmed plans to sell up to 140 million shares of stock and warrants. Proceeds will help finance final studies of its experimental inhaled diabetes drug Afrezza and cancel some debt owed to its founder.
Shares of CytRx Corp. on Thursday fell nearly 20 percent after the cancer drug developer priced a public offering of 8 million common shares at a comparable discount.
HCP Inc. has signed an agreement to buy 133 senior housing communities across the United States in a deal valued at $1.73 billion.
Shares of MannKind Corp. fell nearly 13 percent in after-hours trading on Wednesday after the Valencia biotech said in a regulatory filing that it soon plans to sell shares of its common stock and warrants.
An investment company controlled by billionaire Patrick Soon-Shiong has taken a roughly 9 percent stake in Jakks Pacific Inc., which recently formed a joint venture with another Soon-Shiong company.
The Gores Group said that it has agreed to acquire the maker of a medical device that’s used to treat blood cancer from a unit of New Jersey health care conglomerate Johnson & Johnson.
While the broader markets closed down for the day, Kythera Biopharmaceuticals Inc. was among four companies that saw resounding success in their initial public offering on Thursday, each closing above 20 percent from the opening price.
Response Genetics Inc. said that it has regained compliance with the Nasdaq Capital Market listing requirements.
The Los Angeles City Council on Tuesday voted to repeal a ban on medical marijuana storefront dispensaries.
IPC The Hospitalist Co., a manager of mostly hospital-based physician practices, has acquired Elder Medical Services in Upstate New York.
Kythera Biopharmaceuticals has moved closer to launching an initial public offering of 4 million shares that it expects will price at $14 to $16 a share, according to a filing with the Securities and Exchange Commission.
BIOTECH: FDA snub pushes Imaging3 into bankruptcy.
Imaging3 files for bankruptcy as its 3-D imaging system has yet to take shape.